Trial site
Centre hospitalier universitaire Grenoble-Alpes
- 10running trials
- 4closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia1 trial
- Asthma1 trial
- Brain metastases1 trial
- Childhood cancers1 trial
- Head and neck cancer1 trial
- Heart failure1 trial
- Obesity1 trial
- Obstructive sleep apnoea1 trial
- Ovarian cancer1 trial
- Pancreatic cancer1 trial
- Primary biliary cholangitis1 trial
- Stroke1 trial
- and 3 more
- Phase
- Phase 27 trials
- Status
- Not yet recruiting5 trials
- Completed3 trials
- Recruiting3 trials
- Active, not recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Institut National de la Santé Et de la Recherche Médicale, France2 trials
- University Hospital, Grenoble2 trials
- Abivax S.A.1 trial
- Association Francaise pour la Recherche Thermale1 trial
- Calliditas Therapeutics Suisse SA1 trial
- and 7 more
Running trials
Not yet recruiting
Recruiting
Evaluation of MTX-474 in Participants with Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Safety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Asthma1 recruiting
- Childhood cancers1 recruiting
- Head and neck cancer1 recruiting
- Obesity1 recruiting
- Obstructive sleep apnoea1 recruiting
- Ovarian cancer1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Closed trials
Completed
A Trial to Assess the Efficacy and Safety of OTR4132-MD in Patients With Acute Ischemic Stroke
Terminated
Niraparib as First Line Therapy With Metastatic Homologous Repair-deficient Pancreatic Cancer
Completed
A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026